首页 > 最新文献

Current pulmonology reports最新文献

英文 中文
Overview of Bronchopleural Fistula Management, with a Focus on Bronchoscopic Treatment 支气管胸膜瘘的治疗综述,重点是支气管镜治疗
IF 0.6 Q4 RESPIRATORY SYSTEM Pub Date : 2022-04-08 DOI: 10.1007/s13665-022-00289-3
F. Aliaga, H. Grosu, Macarena R. Vial
{"title":"Overview of Bronchopleural Fistula Management, with a Focus on Bronchoscopic Treatment","authors":"F. Aliaga, H. Grosu, Macarena R. Vial","doi":"10.1007/s13665-022-00289-3","DOIUrl":"https://doi.org/10.1007/s13665-022-00289-3","url":null,"abstract":"","PeriodicalId":72745,"journal":{"name":"Current pulmonology reports","volume":"11 1","pages":"65-73"},"PeriodicalIF":0.6,"publicationDate":"2022-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43282071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bronchoscopic Lung Nodule Ablation 支气管镜下肺结节消融
IF 0.6 Q4 RESPIRATORY SYSTEM Pub Date : 2022-03-31 DOI: 10.1007/s13665-022-00287-5
A. Goizueta, R. Casal
{"title":"Bronchoscopic Lung Nodule Ablation","authors":"A. Goizueta, R. Casal","doi":"10.1007/s13665-022-00287-5","DOIUrl":"https://doi.org/10.1007/s13665-022-00287-5","url":null,"abstract":"","PeriodicalId":72745,"journal":{"name":"Current pulmonology reports","volume":"11 1","pages":"56 - 64"},"PeriodicalIF":0.6,"publicationDate":"2022-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43830272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent Advances in Transbronchial Lung Cryobiopsy 经支气管肺低温活检的最新进展
IF 0.6 Q4 RESPIRATORY SYSTEM Pub Date : 2022-03-28 DOI: 10.1007/s13665-022-00288-4
J. Green, Sridesh Nath, R. Semaan
{"title":"Recent Advances in Transbronchial Lung Cryobiopsy","authors":"J. Green, Sridesh Nath, R. Semaan","doi":"10.1007/s13665-022-00288-4","DOIUrl":"https://doi.org/10.1007/s13665-022-00288-4","url":null,"abstract":"","PeriodicalId":72745,"journal":{"name":"Current pulmonology reports","volume":"1 1","pages":"1-8"},"PeriodicalIF":0.6,"publicationDate":"2022-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45063121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Updated Review of Subglottic Stenosis: Etiology, Evaluation, and Management 声门下狭窄的最新综述:病因、评估和管理
IF 0.6 Q4 RESPIRATORY SYSTEM Pub Date : 2022-03-03 DOI: 10.1007/s13665-022-00286-6
L. Pasick, Mursalin M. Anis, D. Rosow
{"title":"An Updated Review of Subglottic Stenosis: Etiology, Evaluation, and Management","authors":"L. Pasick, Mursalin M. Anis, D. Rosow","doi":"10.1007/s13665-022-00286-6","DOIUrl":"https://doi.org/10.1007/s13665-022-00286-6","url":null,"abstract":"","PeriodicalId":72745,"journal":{"name":"Current pulmonology reports","volume":"11 1","pages":"29 - 38"},"PeriodicalIF":0.6,"publicationDate":"2022-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42996240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Lung Cancer Screening: Review and 2021 Update 肺癌筛查:回顾和2021年更新
IF 0.6 Q4 RESPIRATORY SYSTEM Pub Date : 2022-03-01 DOI: 10.1007/s13665-021-00283-1
Anuradha Ramaswamy
{"title":"Lung Cancer Screening: Review and 2021 Update","authors":"Anuradha Ramaswamy","doi":"10.1007/s13665-021-00283-1","DOIUrl":"https://doi.org/10.1007/s13665-021-00283-1","url":null,"abstract":"","PeriodicalId":72745,"journal":{"name":"Current pulmonology reports","volume":"11 1","pages":"15 - 28"},"PeriodicalIF":0.6,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45238809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Asthma-COPD Overlap 哮喘COPD重叠
IF 0.6 Q4 RESPIRATORY SYSTEM Pub Date : 2022-03-01 DOI: 10.1007/s13665-021-00284-0
A. Sam, M. Kraft
{"title":"Asthma-COPD Overlap","authors":"A. Sam, M. Kraft","doi":"10.1007/s13665-021-00284-0","DOIUrl":"https://doi.org/10.1007/s13665-021-00284-0","url":null,"abstract":"","PeriodicalId":72745,"journal":{"name":"Current pulmonology reports","volume":"1 1","pages":"1-14"},"PeriodicalIF":0.6,"publicationDate":"2022-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43841933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pulmonary Procedures in the COVID-19 Era. COVID-19时代的肺部手术
IF 1.1 Q4 RESPIRATORY SYSTEM Pub Date : 2022-01-01 Epub Date: 2022-03-28 DOI: 10.1007/s13665-022-00285-7
Matt Schimmel, David M Berkowitz

Purpose of review: The purpose of this review is to discuss the impact of the COVID-19 pandemic on pulmonary procedures, including new guidelines, restrictions, techniques, and overall effect on patient care.

Recent findings: SARS-CoV-2 predominately impacts the pulmonary system and can result in a severe lower respiratory tract infection. Early guidelines based largely on data from the SARS epidemic recommended significant restrictions on procedure volume out of concern for healthcare worker safety. Newer data suggests relative safety in performing airway and pleural procedures as long as appropriate precautions are followed and new techniques are utilized. The introduction of effective vaccines and more reliable testing has led to a re-expansion of elective procedures.

Summary: Many guidelines and expert statements exist for the management and practice of pulmonary procedures during the COVID-19 pandemic. A flexible and individualized approach may be necessary as our understanding of COVID-19 continues to evolve.

综述目的:本综述旨在讨论 COVID-19 大流行对肺部手术的影响,包括新指南、限制、技术以及对患者护理的总体影响:最新发现:SARS-CoV-2 主要影响肺部系统,可导致严重的下呼吸道感染。出于对医护人员安全的考虑,早期的指导方针主要基于 SARS 疫情的数据,建议对手术量进行严格限制。最新数据表明,只要遵循适当的预防措施并采用新技术,气道和胸膜手术相对安全。总结:在 COVID-19 大流行期间,有许多关于肺部手术管理和实践的指南和专家声明。随着我们对 COVID-19 的了解不断深入,可能有必要采取灵活和个性化的方法。
{"title":"Pulmonary Procedures in the COVID-19 Era.","authors":"Matt Schimmel, David M Berkowitz","doi":"10.1007/s13665-022-00285-7","DOIUrl":"10.1007/s13665-022-00285-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this review is to discuss the impact of the COVID-19 pandemic on pulmonary procedures, including new guidelines, restrictions, techniques, and overall effect on patient care.</p><p><strong>Recent findings: </strong>SARS-CoV-2 predominately impacts the pulmonary system and can result in a severe lower respiratory tract infection. Early guidelines based largely on data from the SARS epidemic recommended significant restrictions on procedure volume out of concern for healthcare worker safety. Newer data suggests relative safety in performing airway and pleural procedures as long as appropriate precautions are followed and new techniques are utilized. The introduction of effective vaccines and more reliable testing has led to a re-expansion of elective procedures.</p><p><strong>Summary: </strong>Many guidelines and expert statements exist for the management and practice of pulmonary procedures during the COVID-19 pandemic. A flexible and individualized approach may be necessary as our understanding of COVID-19 continues to evolve.</p>","PeriodicalId":72745,"journal":{"name":"Current pulmonology reports","volume":"11 1","pages":"39-47"},"PeriodicalIF":1.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47328846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Connective Tissue Disease-related Interstitial Lung Disease. 结缔组织疾病相关间质性肺病的治疗
IF 1.1 Q4 RESPIRATORY SYSTEM Pub Date : 2022-01-01 Epub Date: 2022-05-03 DOI: 10.1007/s13665-022-00290-w
Sakir Ahmed, Rohini Handa

Purpose of review: This review aims to collate current evidence on the screening, diagnosis, and treatment of various connective tissue disease (CTD)-associated interstitial lung diseases (CTD-ILD) and present a contemporary framework for the management of such patients. It also seeks to summarize treatment outcomes including efficacy and safety of immunosuppressants, anti-fibrotics, and stem cell transplantation in CTD-ILD.

Recent findings: Screening for ILD has been augmented by the use of artificial intelligence, ultra-low dose computerized tomography (CT) of the chest, and the use of chest ultrasound. Serum biomarkers have not found their way into clinical practice as yet. Identifying patients who need treatment and choosing the appropriate therapy is important to minimize the risk of therapy-related toxicity. The first-line drugs for systemic sclerosis (SSc) ILD include mycophenolate and cyclophosphamide. Nintedanib, an anti-fibrotic tyrosine kinase inhibitor, is approved for use in SSc-ILD. The US Food and Drug Administration (FDA) has recently approved tocilizumab subcutaneous injection for slowing the rate of decline in pulmonary function in adult patients with SSc-ILD. Autologous stem cell transplantation may have a role in select cases of SSc-ILD.

Summary: CTD-ILD is a challenging area with diverse entities and variable outcomes. High-resolution CT is the investigative modality of choice. Treatment decisions need to be individualized and are based on patient symptoms, lung function, radiologic abnormalities, and the risk of disease progression. Precision medicine may play an important role in determining the optimal therapy for an individual patient in the future.

综述目的:本综述旨在整理目前有关各种结缔组织病(CTD)相关间质性肺病(CTD-ILD)的筛查、诊断和治疗的证据,并为此类患者的管理提供一个现代框架。报告还试图总结治疗结果,包括免疫抑制剂、抗纤维化药物和干细胞移植在 CTD-ILD 中的疗效和安全性:人工智能、超低剂量胸部计算机断层扫描(CT)和胸部超声的使用加强了对 ILD 的筛查。血清生物标志物尚未进入临床实践。识别需要治疗的患者并选择适当的疗法对于最大限度地降低治疗相关毒性的风险非常重要。治疗系统性硬化症(SSc)ILD的一线药物包括霉酚酸酯和环磷酰胺。Nintedanib是一种抗纤维化酪氨酸激酶抑制剂,已被批准用于SSc-ILD。美国食品和药物管理局(FDA)最近批准了托珠单抗(tocilizumab)皮下注射,用于减缓SSc-ILD成年患者肺功能下降的速度。摘要:CTD-ILD是一个具有挑战性的领域,其病例多样,结果各异。高分辨率CT是首选的检查方式。治疗决策需要个体化,并基于患者的症状、肺功能、放射学异常和疾病进展风险。未来,精准医学可能会在确定个体患者的最佳治疗方案方面发挥重要作用。
{"title":"Management of Connective Tissue Disease-related Interstitial Lung Disease.","authors":"Sakir Ahmed, Rohini Handa","doi":"10.1007/s13665-022-00290-w","DOIUrl":"10.1007/s13665-022-00290-w","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review aims to collate current evidence on the screening, diagnosis, and treatment of various connective tissue disease (CTD)-associated interstitial lung diseases (CTD-ILD) and present a contemporary framework for the management of such patients. It also seeks to summarize treatment outcomes including efficacy and safety of immunosuppressants, anti-fibrotics, and stem cell transplantation in CTD-ILD.</p><p><strong>Recent findings: </strong>Screening for ILD has been augmented by the use of artificial intelligence, ultra-low dose computerized tomography (CT) of the chest, and the use of chest ultrasound. Serum biomarkers have not found their way into clinical practice as yet. Identifying patients who need treatment and choosing the appropriate therapy is important to minimize the risk of therapy-related toxicity. The first-line drugs for systemic sclerosis (SSc) ILD include mycophenolate and cyclophosphamide. Nintedanib, an anti-fibrotic tyrosine kinase inhibitor, is approved for use in SSc-ILD. The US Food and Drug Administration (FDA) has recently approved tocilizumab subcutaneous injection for slowing the rate of decline in pulmonary function in adult patients with SSc-ILD. Autologous stem cell transplantation may have a role in select cases of SSc-ILD.</p><p><strong>Summary: </strong>CTD-ILD is a challenging area with diverse entities and variable outcomes. High-resolution CT is the investigative modality of choice. Treatment decisions need to be individualized and are based on patient symptoms, lung function, radiologic abnormalities, and the risk of disease progression. Precision medicine may play an important role in determining the optimal therapy for an individual patient in the future.</p>","PeriodicalId":72745,"journal":{"name":"Current pulmonology reports","volume":"11 1","pages":"86-98"},"PeriodicalIF":1.1,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062859/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42174177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Donation After Circulatory Death Donors for Lung Transplantation: the US and Worldwide Status 循环死亡后肺移植的捐赠:美国和世界现状
IF 0.6 Q4 RESPIRATORY SYSTEM Pub Date : 2021-11-16 DOI: 10.1007/s13665-021-00281-3
A. Alnajar, A. Sayed, O. Shazly, S. Roberts, A. Ghodsizad, S. Hirji
{"title":"Donation After Circulatory Death Donors for Lung Transplantation: the US and Worldwide Status","authors":"A. Alnajar, A. Sayed, O. Shazly, S. Roberts, A. Ghodsizad, S. Hirji","doi":"10.1007/s13665-021-00281-3","DOIUrl":"https://doi.org/10.1007/s13665-021-00281-3","url":null,"abstract":"","PeriodicalId":72745,"journal":{"name":"Current pulmonology reports","volume":"10 1","pages":"149 - 157"},"PeriodicalIF":0.6,"publicationDate":"2021-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41849090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Assessment and Clinical Utility of the Respiratory Arousal Threshold in Obstructive Sleep-Disordered Breathing 阻塞性睡眠呼吸障碍患者呼吸唤醒阈值的评估及临床应用
IF 0.6 Q4 RESPIRATORY SYSTEM Pub Date : 2021-11-15 DOI: 10.1007/s13665-021-00282-2
Andres R. Chacon, Isabelo Sicsic, M. Zaw, Kori Ascher, A. Abreu, A. Chediak
{"title":"The Assessment and Clinical Utility of the Respiratory Arousal Threshold in Obstructive Sleep-Disordered Breathing","authors":"Andres R. Chacon, Isabelo Sicsic, M. Zaw, Kori Ascher, A. Abreu, A. Chediak","doi":"10.1007/s13665-021-00282-2","DOIUrl":"https://doi.org/10.1007/s13665-021-00282-2","url":null,"abstract":"","PeriodicalId":72745,"journal":{"name":"Current pulmonology reports","volume":"10 1","pages":"143 - 148"},"PeriodicalIF":0.6,"publicationDate":"2021-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46412011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current pulmonology reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1